Pumpinheart
About Pumpinheart
Heart failure remains one of the most urgent unmet needs in cardiology, especially HFpEF (Heart Failure with preserved Ejection Fraction), which accounts for over half of all heart failure cases yet lacks effective device-based therapies. Pumpinheart is addressing this gap with the world’s first transcatheter, implantable diastolic heart pump, engineered to reduce left atrial pressure during diastole and improve cardiac filling.
A spin-out from the
Royal College of Surgeons in Ireland (RCSI) , Pumpinheart is pioneering a new category of minimally invasive mechanical circulatory support to transform outcomes for millions of HFpEF patients. Supported by clinical and scientific leaders across Europe and the U.S., the company is entering a pivotal phase of validation, regulatory planning, and commercialization.
This role offers a rare opportunity to shape a
first-in-class cardiac device
with the potential to redefine HFpEF treatment globally.
The Opportunity
Pumpinheart is forming a select Advisory Board of heart failure experts, interventional cardiologists, cardiac surgeons (with MCS & Transplant specialization), medtech innovators, and strategic investors. We are seeking an experienced
Cardiologist Advisor
to help guide our clinical development, regulatory strategy, and adoption pathways.
As a Cardiologist Advisor, you will play a critical role in shaping: Clinical strategy, patient selection, and HFpEF care pathways Clinical trial endpoints, safety considerations, and feasibility planning Integration into cardiology, heart failure, and cath-lab workflows Real-world adoption models and physician usability KOL introductions, health-system partnerships, and academic collaborations Geographic expansion across U.S. and EU cardiovascular networks
Advisors receive early visibility into Pumpinheart’s current and upcoming funding rounds, with opportunities to participate alongside medtech investors and institutional partners.
Key Responsibilities
Clinical Strategy & Workflow Integration Define patient profiles and HFpEF phenotypes suitable for device therapy Guide integration into HF clinics, cardiology workflows, and procedural settings Provide clinical insight on performance metrics and outcome measures
Trial Design & Regulatory Support Advise on early feasibility study design, endpoints, safety parameters, and trial site selection Support engagement with regulators across U.S., EU, and international markets
Go-to-Market & Strategic Connections Introduce Pumpinheart to HF programs, cardiology groups, cath-lab directors, and health systems Support expansion into key U.S. and EU geographies Identify and connect clinical champions and early adopters
Product & Market Insight Provide feedback on device usability, implantation workflow, and interventional practicality Offer insights on adoption barriers, pricing models, and reimbursement opportunities
Ideal Advisor Profile
We are especially interested in individuals with at least
3
of the following: 10+ years of clinical experience in cardiology, heart failure, or interventional cardiology Experience with device-based therapies, hemodynamics, or diastolic dysfunction Prior involvement in early-stage medical device companies or clinical trials Strong network across cardiology practices, HF centers, or academic institutions Familiarity with FDA/EU device pathways and real-world adoption challenges Interest in minimally invasive cardiac technologies and breakthrough HF solutions Passion for improving HFpEF outcomes through next-generation device innovation
Founding Team
Donald Hickey — Co-Founder & CEO Serial entrepreneur with a background in scaling technology ventures. Leads corporate strategy, fundraising, and cross-functional execution. Dr. Aamir Hameed — Co-Founder & CMO Clinician-scientist at RCSI with a background in cardiothoracic surgery and regenerative medicine. Guides clinical strategy and translational development. Dr. Andrew Malone — Co-Founder & CSO Medical physicist specializing in cardiovascular device design and simulation. Leads prototyping, bench testing, and engineering R&D. Jonathan Bouchier-Hayes — Non-Executive Director CEO of Endowave with extensive experience in bringing minimally invasive medtech innovations to market. Dr. Faisal H. Cheema — Non-Executive Director Renowned physician-scientist and Associate Professor at University of Houston. Advises on scientific strategy, trial design, and academic partnerships.
Compensation & Engagement Equity-based advisory compensation 1–2 hours/month
(virtual participation) Access to internal strategy sessions, clinical materials, and investor updates Option to participate in Pumpinheart’s current or future funding rounds
Equal Opportunity Commitment
Pumpinheart is committed to building a diverse, mission-driven advisory team. We welcome professionals from all backgrounds and are proud to be an equal opportunity organization.
Heart failure remains one of the most urgent unmet needs in cardiology, especially HFpEF (Heart Failure with preserved Ejection Fraction), which accounts for over half of all heart failure cases yet lacks effective device-based therapies. Pumpinheart is addressing this gap with the world’s first transcatheter, implantable diastolic heart pump, engineered to reduce left atrial pressure during diastole and improve cardiac filling.
A spin-out from the
Royal College of Surgeons in Ireland (RCSI) , Pumpinheart is pioneering a new category of minimally invasive mechanical circulatory support to transform outcomes for millions of HFpEF patients. Supported by clinical and scientific leaders across Europe and the U.S., the company is entering a pivotal phase of validation, regulatory planning, and commercialization.
This role offers a rare opportunity to shape a
first-in-class cardiac device
with the potential to redefine HFpEF treatment globally.
The Opportunity
Pumpinheart is forming a select Advisory Board of heart failure experts, interventional cardiologists, cardiac surgeons (with MCS & Transplant specialization), medtech innovators, and strategic investors. We are seeking an experienced
Cardiologist Advisor
to help guide our clinical development, regulatory strategy, and adoption pathways.
As a Cardiologist Advisor, you will play a critical role in shaping: Clinical strategy, patient selection, and HFpEF care pathways Clinical trial endpoints, safety considerations, and feasibility planning Integration into cardiology, heart failure, and cath-lab workflows Real-world adoption models and physician usability KOL introductions, health-system partnerships, and academic collaborations Geographic expansion across U.S. and EU cardiovascular networks
Advisors receive early visibility into Pumpinheart’s current and upcoming funding rounds, with opportunities to participate alongside medtech investors and institutional partners.
Key Responsibilities
Clinical Strategy & Workflow Integration Define patient profiles and HFpEF phenotypes suitable for device therapy Guide integration into HF clinics, cardiology workflows, and procedural settings Provide clinical insight on performance metrics and outcome measures
Trial Design & Regulatory Support Advise on early feasibility study design, endpoints, safety parameters, and trial site selection Support engagement with regulators across U.S., EU, and international markets
Go-to-Market & Strategic Connections Introduce Pumpinheart to HF programs, cardiology groups, cath-lab directors, and health systems Support expansion into key U.S. and EU geographies Identify and connect clinical champions and early adopters
Product & Market Insight Provide feedback on device usability, implantation workflow, and interventional practicality Offer insights on adoption barriers, pricing models, and reimbursement opportunities
Ideal Advisor Profile
We are especially interested in individuals with at least
3
of the following: 10+ years of clinical experience in cardiology, heart failure, or interventional cardiology Experience with device-based therapies, hemodynamics, or diastolic dysfunction Prior involvement in early-stage medical device companies or clinical trials Strong network across cardiology practices, HF centers, or academic institutions Familiarity with FDA/EU device pathways and real-world adoption challenges Interest in minimally invasive cardiac technologies and breakthrough HF solutions Passion for improving HFpEF outcomes through next-generation device innovation
Founding Team
Donald Hickey — Co-Founder & CEO Serial entrepreneur with a background in scaling technology ventures. Leads corporate strategy, fundraising, and cross-functional execution. Dr. Aamir Hameed — Co-Founder & CMO Clinician-scientist at RCSI with a background in cardiothoracic surgery and regenerative medicine. Guides clinical strategy and translational development. Dr. Andrew Malone — Co-Founder & CSO Medical physicist specializing in cardiovascular device design and simulation. Leads prototyping, bench testing, and engineering R&D. Jonathan Bouchier-Hayes — Non-Executive Director CEO of Endowave with extensive experience in bringing minimally invasive medtech innovations to market. Dr. Faisal H. Cheema — Non-Executive Director Renowned physician-scientist and Associate Professor at University of Houston. Advises on scientific strategy, trial design, and academic partnerships.
Compensation & Engagement Equity-based advisory compensation 1–2 hours/month
(virtual participation) Access to internal strategy sessions, clinical materials, and investor updates Option to participate in Pumpinheart’s current or future funding rounds
Equal Opportunity Commitment
Pumpinheart is committed to building a diverse, mission-driven advisory team. We welcome professionals from all backgrounds and are proud to be an equal opportunity organization.